DOD Biotech PCL (BKK:DOD-R) EV-to-EBIT : -4.59 (As of Jul. 24, 2025)

View and export this data going back to 2018. Start your Free Trial

What is DOD Biotech PCL EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, DOD Biotech PCL's Enterprise Value is ฿669.6 Mil. DOD Biotech PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was ฿-146.0 Mil. Therefore, DOD Biotech PCL's EV-to-EBIT for today is -4.59.

The historical rank and industry rank for DOD Biotech PCL's EV-to-EBIT or its related term are showing as below:

BKK:DOD-R' s EV-to-EBIT Range Over the Past 10 Years
Min: -14.13 Med: 14.07 Max: 51.96
Current: -4.59

During the past 11 years, the highest EV-to-EBIT of DOD Biotech PCL was 51.96. The lowest was -14.13. And the median was 14.07.

BKK:DOD-R's EV-to-EBIT is ranked worse than
100% of 1536 companies
in the Consumer Packaged Goods industry
Industry Median: 13.81 vs BKK:DOD-R: -4.59

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. DOD Biotech PCL's Enterprise Value for the quarter that ended in Mar. 2025 was ฿430.9 Mil. DOD Biotech PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was ฿-146.0 Mil. DOD Biotech PCL's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was -33.89%.

DOD Biotech PCL EV-to-EBIT Historical Data

The historical data trend for DOD Biotech PCL's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DOD Biotech PCL EV-to-EBIT Chart

DOD Biotech PCL Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EV-to-EBIT

Get a 7-Day Free Trial

11.10

16.91

-4.78

18.24

12.75

DOD Biotech PCL Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EV-to-EBIT	Get a 7-Day Free Trial															13.11	-8.59	-11.66	12.75	-2.61

Competitive Comparison of DOD Biotech PCL's EV-to-EBIT

For the Packaged Foods subindustry, DOD Biotech PCL's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DOD Biotech PCL's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, DOD Biotech PCL's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where DOD Biotech PCL's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

DOD Biotech PCL EV-to-EBIT Calculation

DOD Biotech PCL's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	669.595	/	-146.038
	=	-4.59

DOD Biotech PCL's current Enterprise Value is ฿669.6 Mil.
DOD Biotech PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿-146.0 Mil.

DOD Biotech PCL (BKK:DOD-R) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

DOD Biotech PCL's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2025 )	=	EBIT	/	Enterprise Value (Q: Mar. 2025 )
	=	-146.038	/	430.87404
	=	-33.89 %

DOD Biotech PCL's Enterprise Value for the quarter that ended in Mar. 2025 was ฿430.9 Mil.
DOD Biotech PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿-146.0 Mil.

DOD Biotech PCL EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of DOD Biotech PCL's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

DOD Biotech PCL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » DOD Biotech PCL (BKK:DOD-R) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

DOD:Thailand

Address

No. 111, Moo 2, Tumbol Taa jeen, Amphor Muengsamutsakhon, Samut Sakhon, THA, 74000

Website

https://www.dodbiotech.com

DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The company is organized into business units based on its products and services and has reportable segments as; Supplementary business, Manufacturing cosmetic business, Manufacturing extraction business, and others. A majority of its revenue is generated from the Supplementary business which manufactures and sells dietary supplements in the form of capsules, tablets, soft gels, gummies, probiotics, shot drinks, and others. Geographically, the company operates only in Thailand.

DOD Biotech PCL Headlines

No Headlines